Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 872 across all filing types
Latest filing 2021-09-29 Capital/Financing Update
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
ADR receives AUS R&D Tax Incentive and Team Build Out Update 2 pages 116.7KB
Capital/Financing Update Classification · 95% confidence The document is an announcement from Adherium Limited regarding the receipt of $370,000 Australian R&D Tax Incentive for the 2020 financial year and updates on their team build-out. It discusses government support, investment in research and development, and strategic hiring but does not contain any financial statements, detailed financial performance data, or comprehensive report content. The document is relatively short (4155 characters) and reads as a corporate update or news release rather than a formal financial report or regulatory filing. There is no indication that this is an annual report, interim report, earnings release, or any other detailed financial document. It is an update on financing-related activity (receipt of government R&D tax incentive funds) and company operational updates related to team expansion. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-09-29 English
Update - Notification of buy-back - ADR 6 pages 27.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Notification of buy-back' and contains detailed information about the company's share buy-back activities, including the number of securities bought back, type of buy-back (Employee share scheme buy-back), dates, and consideration details. It is a daily update announcement regarding the buy-back of shares, not a full financial report or earnings release. The content matches the description of a 'Transaction in Own Shares' filing, which reports on the company's repurchase of its own shares. The document length is 4837 characters, which is sufficient to contain substantive details of the buy-back transaction rather than just an announcement of a report publication. Therefore, the correct classification is POS (Transaction in Own Shares).
2021-09-27 English
Update - Notification of buy-back - ADR 6 pages 26.8KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Notification of buy-back' and repeatedly references details about a buy-back of shares by Adherium Limited, including the number of securities bought back, the type of buy-back (Employee share scheme buy-back), and the total consideration paid. It is an announcement providing detailed information about the completion of a share buy-back transaction. There is no indication of financial statements, earnings data, or management discussion. The document is relatively short (4401 characters) and is clearly an update/notification about a capital transaction. According to the filing definitions, this fits best under 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. Therefore, the correct classification is POS with high confidence.
2021-09-27 English
Change in substantial holding 2 pages 85.6KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' under the Corporations Act 2001, Section 671B, which is a notice of change of interests of a substantial holder. It details changes in voting power, securities held, and transactions related to substantial shareholdings. The content focuses on reporting changes in significant share ownership levels, including dates, number of shares, and nature of transactions. There is no indication of financial performance data, management commentary, or other report types. This type of filing corresponds to notifications about major shareholding changes, which aligns with the category 'Major Shareholding Notification' (MRQ). The document length is substantial and contains detailed data, confirming it is the actual notice rather than a brief announcement or certification.
2021-09-27 English
Notice of Annual General Meeting/Proxy Form 25 pages 655.8KB
AGM Information Classification · 100% confidence The document is titled 'Notice of Annual General Meeting' and details the logistics of the AGM, including date, time, venue, voting procedures, and proxy instructions. It includes the agenda items such as receiving the annual financial report, adoption of the remuneration report, election of directors, and other shareholder resolutions. The document does not contain the actual financial statements or detailed reports but rather serves as a formal notice to shareholders about the meeting and the resolutions to be voted on. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting, specifically notices and agendas. The document length is substantial but it is clearly a notice rather than the full annual report or financial statements. Therefore, the correct classification is AGM Information (AGM-R).
2021-09-26 English
Adherium awarded US-based AZ clinical study supply contract 2 pages 111.1KB
Regulatory Filings Classification · 95% confidence The document is an announcement by Adherium Limited regarding a contract awarded for supply of sensors and software to AstraZeneca for a clinical study. It discusses the contract details, revenue expectations, and company background. There is no financial report, earnings data, or regulatory filing content. The document is a corporate announcement about a contract win, which fits best under general regulatory announcements or miscellaneous filings that do not fit other categories. The document length is short (2783 characters), and it is not a report or presentation. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-09-23 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.